Search

Your search keyword '"Drospirenone -- Intellectual property"' showing total 37 results
Start Over Descriptor "Drospirenone -- Intellectual property" Topic women -- health aspects
37 results on '"Drospirenone -- Intellectual property"'

1. Researchers Submit Patent Application, 'Use Of Combined Oral Contraceptives Containing Nomegestrol Acetate And Estradiol', for Approval (USPTO 20230398127)

Subjects
Estradiol -- Intellectual property, Women -- Health aspects, Drospirenone -- Intellectual property, Phenols -- Intellectual property, Contraceptives -- Intellectual property, Acetates -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 JAN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor BOOLELL, [...]

Published
2024

2. Researchers Submit Patent Application, 'Methods Of Contraception Using Nomegestrol Acetate And Estradiol', for Approval (USPTO 20230390306)

Subjects
Estradiol -- Intellectual property, Women -- Health aspects, Drospirenone -- Intellectual property, Phenols -- Intellectual property, Contraceptives -- Intellectual property, Norgestimate -- Intellectual property, Transdermal medication -- Intellectual property, Acetates -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 DEC 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor BOOLELL, [...]

Published
2023

3. Researchers Submit Patent Application, 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same', for Approval (USPTO 20230372248)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors DROUIN, [...]

Published
2023

6. 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' in Patent Application Approval Process (USPTO 20230046871)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 MAR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DROUIN, Dominique (Verrieres-le-Buisson, FR); PERRIN, Philippe (Paris, FR); [...]

Published
2023

10. 'Use Of Neuropilin Antagonists For The Treatment Of Endometriosis' in Patent Application Approval Process (USPTO 20230000832)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Hydroxyprogesterone -- Intellectual property, Norgestimate -- Intellectual property, Cell receptors, Endometriosis, Health, Women's issues/gender studies
Abstract

2023 JAN 26 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors GOGUSEV, Jean (Paris, FR); LEPELLETIER, Yves (Paris, FR); [...]

Published
2023

11. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11504334)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 DEC 15 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

Published
2022

12. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11491113)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 DEC 1 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

Published
2022

14. Researchers Submit Patent Application, 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same', for Approval (USPTO 20220339107)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 NOV 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors DROUIN, [...]

Published
2022

15. Patent Application Titled 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' Published Online (USPTO 20220339106)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 NOV 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2022

16. 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' in Patent Application Approval Process (USPTO 20220339165)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 NOV 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DROUIN, Dominique (Verrieres-le-Buisson, FR); PERRIN, Philippe (Paris, FR); [...]

Published
2022

17. Mithra's NEXTSTELLIS(R) granted additional patent in the United States

Subjects
Euronext Brussels S.A./N.V. -- Intellectual property, Women -- Health aspects, Drospirenone -- Intellectual property, Securities industry -- Intellectual property, Securities industry, Business, international, Nextstellis (Contraceptive) -- Intellectual property
Abstract

(GLOBE NEWSWIRE via COMTEX) -- Mithra's NEXTSTELLIS(R) granted additional patent in the United States - New patent extends protection for NEXTSTELLIS(R) (ESTELLE(R)) until 2036 - Mayne Pharma has a 20-year [...]

Published
2023

18. Mithra's NEXTSTELLIS(R) granted additional patent in the United States

Subjects
Euronext Brussels S.A./N.V. -- Intellectual property, Women -- Health aspects, Drospirenone -- Intellectual property, Securities industry -- Intellectual property, Securities industry, Banking, finance and accounting industries, Business, Nextstellis (Contraceptive) -- Intellectual property
Abstract

Mithra's NEXTSTELLIS [sup. (R) ] granted additional patent in the United States New patent extends protection for NEXTSTELLIS [sup. (R) ] (ESTELLE [sup. (R) ] ) until 2036 Mayne Pharma [...]

Published
2023

19. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11452695)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 OCT 20 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Drouin, Dominique (Verrieres-le-Buisson, FR), Perrin, Philippe (Paris, FR), Velada, [...]

Published
2022

21. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11439598)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 OCT 6 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Drouin, Dominique (Verrieres-le-Buisson, FR), Perrin, Philippe (Paris, FR), Velada, [...]

Published
2022

22. 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' in Patent Application Approval Process (USPTO 20220241209)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 AUG 25 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DROUIN, Dominique (Verrieres-le-Buisson, FR); PERRIN, Philippe (Paris, FR); [...]

Published
2022

23. Researchers Submit Patent Application, 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same', for Approval (USPTO 20220218615)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 AUG 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors DROUIN, [...]

Published
2022

24. 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' in Patent Application Approval Process (USPTO 20220192991)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DROUIN, Dominique (Verrieres-le-Buisson, FR); PERRIN, Philippe (Paris, FR); [...]

Published
2022

25. Researchers Submit Patent Application, 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same', for Approval (USPTO 20220183984)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 JUL 7 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors DROUIN, [...]

Published
2022

26. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11351122)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 JUN 30 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

Published
2022

27. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11291633)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 APR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Laboratorios Leon Farma SA (Leon, Spain) has been issued patent number 11291632, according to [...]

Published
2022

28. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11291632)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 APR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Laboratorios Leon Farma SA (Leon, Spain) has been issued patent number 11291632, according to [...]

Published
2022

29. 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' in Patent Application Approval Process (USPTO 20220040113)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 MAR 3 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DROUIN, Dominique (Verrieres-le-Buisson, FR); PERRIN, Philippe (Paris, FR); [...]

Published
2022

30. 'Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen' in Patent Application Approval Process (USPTO 20210346397)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Phenols -- Intellectual property, Norgestimate -- Intellectual property, Contraceptives -- Intellectual property, Drug approval, Estrogen, Health, Women's issues/gender studies
Abstract

2021 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventor RUBIN, Arkady (Flemington, NJ, US), filed on July [...]

Published
2021

31. Patent Application Titled 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' Published Online (USPTO 20210299146)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 OCT 21 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2021

32. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11123299)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 OCT 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Drouin, Dominique (Verrieres-le-Buisson, FR), Perrin, Philippe (Paris, FR), Velada, [...]

Published
2021

33. Patent Issued for Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen (USPTO 11103515)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Phenols -- Intellectual property, Norgestimate -- Intellectual property, Contraceptives -- Intellectual property, Estrogen, Health, Women's issues/gender studies
Abstract

2021 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Rubin, Arkady (Flemington, NJ, US), filed on December 10, [...]

Published
2021

34. 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' in Patent Application Approval Process (USPTO 20210213035)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 AUG 5 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DROUIN, Dominique (Verrieres-le-Buisson, FR); PERRIN, Philippe (Paris, FR); [...]

Published
2021

35. Patent Application Titled 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' Published Online (USPTO 20210128585)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 JUN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2021

36. 'Stable Pharmaceutical Compositions Containing Estradiol And Progesterone For Oral Administration' in Patent Application Approval Process (USPTO 20210121480)

Subjects
United States. Food and Drug Administration, Women -- Health aspects, Estradiol -- Intellectual property, Drospirenone -- Intellectual property, Phenols -- Intellectual property, Conjugated estrogens -- Intellectual property, Progesterone -- Intellectual property, Norgestimate -- Intellectual property, Health, Women's issues/gender studies, Prometrium (Medication) -- Intellectual property
Abstract

2021 MAY 20 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Prattipati, Vijayabhanu (Hyderabad, IN); Keesara, Venkateshwar Reddy (Hyderabad, [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results